…
Strong operating leverage and profitability inflection attract more shareholders and bode well for Hims & Hers stock. Find out if…
Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) - Seaport Res Ptn lifted their Q2 2024 earnings per…
Hims & Hers is rapidly innovating its technology platform and improving profitability. Read more to see what makes HIMS stock…
…
Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) saw strong trading volume on Tuesday following a…
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) was the target of unusually large options trading activity on…
Online health and wellness company Hims & Hers bumped its full-year revenue forecast higher following strong growth in subscribers and…
Hims & Hers stock target, maintains hold on first quarter results…
Shares of growth stock Hims & Hers Health (NYSE: HIMS) jumped as much as 17.1% in trading on Tuesday after…
Strong earnings have sent this healthcare company higher today.…
Hims & Hers Health reported total revenue of $278.2 million, a 46% year-on-year growth and higher than Street expectations of…
Hims & Hers Health seems to be heading back to the prior highs. See why investors should use the recent weakness to buy more…
After the market close on Monday, Hims & Hers Health reported strong first-quarter results that included revenue of $278.2 million,…
Hims & Hers Health reported total revenue of $278.2 million, a 46% year-on-year growth and higher than Street expectations of…
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the recipient of some unusual options trading on Tuesday.…
Hims & Hers Health (HIMS) stock is popular with options bulls today, thanks to the telehealth companys quarterly win…
Hims & Hers Health (NYSE:HIMS) Sees Strong Trading Volume After Strong Earnings…
Hims & Hers Health, Inc. beats earnings expectations. Reported EPS is $0.04852, expectations were $0.02. Hims & Hers Health, Inc.…
Hims & Hers Health Inc (HIMS), a prominent player in the consumer packaged goods industry, has experienced a notable fluctuation…
Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price…
Shares of Hims & Hers Health Inc. (NYSE: HIMS) are jumping by as much as 15.5% after the company released…
Deutsche Bank Aktiengesellschaft boosted their price target on shares of Hims & Hers Health from $14.00 to $16.00 and gave…
Hims & Hers Health (NYSE:HIMS - Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.05…
These are the stocks posting the largest moves in early trading.…
Kevin OLeary, the host of "Shark Tank," criticized Andrew Dudum, the CEO of Hims & Hers, for his support of…
Earnings call: Hims & Hers reports strong Q1 growth, plans expansion…
Impressive Q1 results with significant revenue growth, subscriber increase, and strategic share repurchases underscore Hims & Hers Healths upward trajectory.…
HIMS stock results show that Hims & Hers Health beat analyst estimates for earnings per share and beat on revenue…
"Youre serving yourself. And for that I call you an idiot, and I whack you," OLeary said of Hims &…
On Monday, major U.S. stock indexes experienced gains, with the S&P500 closing nearly 1% higher at 5,180.74, the Dow Jones…
…
Earnings call: Hims & Hers reports strong Q1 growth, plans expansion…
Hims & Hers co-founder and CEO Andrew Dudum used the companys first-quarter earnings call to clarify a recent social media…
Hims & Hers Health (NYSE:HIMS) Shares Gap Up to $11.26…
The CEO of Hims & Hers tries backtracking from his desire to hire anti-Israel, Hamas-loving college protesters after stock tanks…
After announcing revised 2024 revenue guidance and strong Q1 results, Hims & Hers Health (HIMS) sees an 11% increase in…
Hims & Hers Health reported quarterly GAAP earnings of 5 cents per share which beat the analyst consensus estimate of…
Kevin OLeary sounded off on Hims & Hers CEO Andrew Dudum over his initial support of the anti-Israel protests and…
Dudum wrote on X that his words were “misconstrued by some” and reiterated that all students should feel safe at…
Hims & Hers Healths stock dropped 5% due to controversial comments by the CEO. Click here as I look at…
…
The CEO of Hims & Hers, a telehealth pharmaceutical company, has issued a new statement on the campus protests happening…
The CEO had initially said that there are "plenty" of companies ready to hire the protesters, "regardless of university discipline.…
…
Dudum is taking heat from social media users and other tech-sector founders over the stance.…
Andrew Dudum even encouraged those gathered at universities to continue protesting against "the genocide of the Palestinian people."…
Hims & Hers founder and CEO Andrew Dudum walked back his praise of anti-Israel protesters after his firm’s stock value…
Shares of Hims & Hers Health (HIMS) rebounded premarket Monday following a sharp drop on Friday amid controversial tweets from…
…